NorInvent AB is a development company in the field of life science, which develops Drug Delivery platforms. The technology, XtriG, is based on carbohydrates bound to a membrane- The company develops technologies so that carbohydrate chains can act as carriers/transporters of drug substances. The company's XtriG technology is patented and is preliminary an excipient - the vehicle or medium - for drug substances.
NorInvent has a dynamic organization with a minimal number of employees where competencies are contracted as needed. This ensures the highest quality in each field while achieving a cost-effective operation.
The board includes persons with experience of leading positions in the pharmaceutical industry.